THERAVANCE BIOPHARMA INC (TBPH) Stock Income Statement
NASDAQ:TBPH • KYG8807B1068
Current stock price
16.46 USD
+0.15 (+0.92%)
At close:
16.46 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 107.46M | 64.38M | 57.42M | 51.30M | 55.30M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 111.07M | 106.82M | 110.72M | 130.40M | 293.00M | |||
| Research and Development | 37.41M | 37.64M | 40.62M | 63.40M | 192.30M | |||
| Selling, General, and Administrative Expenses | 73.65M | 69.17M | 70.09M | 67.10M | 100.70M | |||
| Operating Income | -3.60M | -42.44M | -53.29M | -79.10M | -237.70M | |||
| Interest Income/Expense | 82.85M | 2.33M | 6.77M | 2.20M | -7.40M | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Non Recurring Items | 50.00M | -4.51M | -2.74M | -15.90M | -20.10M | |||
| Income Before Taxes | 129.25M | -44.61M | -49.27M | -92.80M | -265.20M | |||
| Income Tax | 23.35M | 11.80M | 5.92M | 0.00 | -200.00K | |||
| Net Income | 105.89M | -56.42M | -55.19M | 872.10M | -199.40M | |||
| EBITDA | -1.98M | -40.73M | -51.29M | -75.38M | -231.79M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.06 | -1.16 | -1.00 | 11.84 | -2.86 | |||
| Non GAAP EPS | -0.53 | -1.09 | -0.97 | -0.67 | -2.95 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | 98.54% | -87.63% | -96.11% | 1700.00% | -360.58% | |||
| Operating Profit Margin | -3.35% | -65.91% | -92.80% | -154.19% | -429.84% | |||
All data in USD